Found: 3
Select item for more details and to access through your institution.
Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia.
- Published in:
- Archives of Biological Sciences, 2023, v. 75, n. 3, p. 251, doi. 10.2298/ABS230316020K
- By:
- Publication type:
- Article
Combined analysis of KRAS mutation and p16<sup>INK4a</sup> and p14<sup>ARF</sup> methylation status in locally advanced rectal carcinoma treated with preoperative chemoradiotherapy.
- Published in:
- Archives of Biological Sciences, 2022, v. 74, n. 2, p. 127, doi. 10.2298/ABS220222011K
- By:
- Publication type:
- Article
RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin.
- Published in:
- Archives of Biological Sciences, 2022, v. 74, n. 1, p. 57, doi. 10.2298/ABS211208004K
- By:
- Publication type:
- Article